<DOC>
	<DOCNO>NCT02129010</DOCNO>
	<brief_summary>Prospective clinical study investigate pathogenesis Terson syndrome prognostic value CSF-biomarkers tau-protein amyloid-β 40 42 patient aneurysmatic subarachnoid hemorrhage . Our two hypothesis follow : 1 . The incidence Terson syndrome correlate initial intracranial opening pressure ( measure extra ventricular drain ) 2 . The CSF-biomarkers correlate outcome assess discharge , 3- , 6- 12-months postictally use Glasgow-Outcome-Scale-Extended ( GOSE ) Euro-Qol-5 well complication relate aneurysmatic subarachnoid hemorrhage cerebral vasospasm , delayed cerebral ischemia re-bleed .</brief_summary>
	<brief_title>The Pathogenesis Terson Syndrome Role CSF Tau / Amyloid-ß 40 42 Patients With Aneurysmatic Subarachnoid Hemorrhage</brief_title>
	<detailed_description>In prospective clinical study pathogenesis Terson syndrome prognostic value CSF-biomarkers tau-proteine amyloid-β 40 42 patient aneurysmatic subarachnoidal hemorrhage investigate . Intracranial opening pressure measure patient require CSF-diversion acute hydrocephalus correlate incidence Terson syndrome test opthalmologic exam ( group A : Terson syndrome positive , group B : Terson syndrome negative ) . CSF sample external ventricular drainage obtain day 0 , 2 6 concentration tau-protein amyloid-β 40 42 determine correlated secondary outcome measure delay cerebral ischemia , clinical vasospasm , re-bleed , necessity surgical intervention secondary raise intracranial pressure CSF-diversion . Outcome term Glasgow-Outcome-Scale-Extended Euro-Qol-5 assess 3 , 6 12 month . CSF patient undergo diagnostic therapeutic tap internal ventricle normal pressure hydrocephalus shunt diagnostics serve reference CSF-biomarkers concentration healthy individual .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>old 18 year diagnosis subarachnoid hemorrhage secondary intracranial aneurysm aneurysmatic subarachnoid hemorrhage must principal diagnosis hospitalization intracranial aneurysm must confirm imaging ( Computed tomography , magnet resonance tomography angiography ) Patients require diagnostic/therapeutic tap internal ventricle CSFdiversion ( shunt ) normal pressure hydrocephalus shunt diagnostics serve control group inform consent young 18 year diagnosis traumatic perimesencephalic subarachnoid hemorrhage without intracranial aneurysm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>subarachnoid hemorrhage</keyword>
	<keyword>terson syndrome</keyword>
	<keyword>CSF-proteines</keyword>
	<keyword>phospho-tau</keyword>
	<keyword>beta-amyloid</keyword>
</DOC>